Public Citizen

  • Skip to navigation [n]
  • Skip to content [c]
  • Skip to footer [f]

Menu

  • About Us
  • Victories
  • News
  • Search
  • Get Updates
    Close

    Valid email is required

  • Act
  • Donate

    Donate

    • Donate
    • Join/Renew
    • Giving Through Your Will
    • Gift of Stocks or Mutual Funds
    • Tax-Deductible Giving
    • Charitable Gift Annuities
    • Gifts From Your Retirement Account
    • Life Insurance Donations
Close

  • Protecting Democracy [1]

    American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

    Tell Congress: Pass the Protecting Our Democracy Act

    Add Your Name

    Coalition Calls on Americans to Reject Trump’s Threat to the Rule of Law and U.S. Democracy

    Public Citizen’s Lisa Gilbert on Why Now is the Time to Repair American Democracy

  • Making Government Work [2]

    The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

    Get Corporate Money Out of Politics

    Sign the Petition

    How Corporate Lobbyists Use the Executive Branch to Halt Progress

    It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

  • Consumer & Worker Safeguards [3]

    Every day, big banks, big polluters and big tech companies are threatening our economy, our environment and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

    Don’t Let Big Tech Write Our Digital Privacy Laws

    Sign Now

    Poll: 71% of Voters Support Strong Regulation to Protect the Public

    Amazon’s Pandemic Price Gouging Shows Need for New Federal Law

  • Safe & Affordable Drugs & Devices [4]

    Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

    Fight Pharma Greed

    Take Action Now

  • Health Care [5]

    Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

    Win Medicare for All

    Take Action Now

    Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2017-2019

    Statement: FDA Must Reject Tanezumab as a Treatment for Osteoarthritis Due to Unacceptable Dangers, Little to No Benefit

  • Globalization & Trade [6]


    Our Mission



    Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives. Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely. For decades, we have fought for progressive alternatives that benefit people and the planet.

    Send a message to the White House demanding bold action to stop COVID-19 and end the pandemic!

    Take Action

    Undemocratic WTO Processes Produce Shameful Result on Intellectual Property and Covid at 12th WTO Ministerial

    WTO Text Would Undermine Global Access to Medicines

  • Climate & Energy [7]

    The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

    Ask Your Senators to Pass the Fossil Free Finance Act

    Call Now

    Climate Roadmap for U.S. Financial Regulation

    We Must Pass a Green New Deal

  • Justice & the Courts [8]

    Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

    Subscribe to the Supreme Court Conference Preview

    Sign Up

Share
  • Facebook
  • Twitter
  • Email

Drug Safety

Share
  • Facebook
  • Twitter
  • Email

More Information on Drug Safety

  • Keynote Address by Sidney Wolfe, MD at “Selling Sickness” Conference, February 21, 2013
  • Petition to the FDA for Black Box Warnings on ACE Inhibitors, ARBs, and Aliskiren, October 4, 2012
  • Letter to FDA Addressing Recent Failures to Disclose New Drug Application Approval Packages in Timely Manner, July 23, 2012
  • Letter on the Ability of Drug Companies to Add Safety Warnings to Their Products’ Labels, March 17, 2008
  • Congressional Testimony on FDA Deficiencies, February 27, 2008
  • Regulatory Affairs Journal Article: The U.S. FDA at a Crossroads, July 2006
  • Statement on the 100th Anniversary of the FDA, June 27, 2006
  • Testimony on Developing Cancer Biomarkers: A Case Study Involving ACF/Orlistat (Xenical), June 15, 2006
  • Comments on Good Manufacturing Practices for Phase I Clinical Trial Drugs, April 3, 2006
  • Testimony on the U.S. Drug Safety System, January 19, 2006
  • Letter Detailing Needed Improvements to FDA’s MedWatch Adverse Events Reporting System, February 25, 2005
  • Letter in BMJ on the New Zealand Ministry of Health Decision to Stop Funding Medsafe Program, August 23, 2004
  • Article in JGIM: Remedies Needed in Reporting Adverse Reactions and FDA Use of Reports, January 31, 2003
  • Op-Ed in Pharmacoepidemiology and Drug Safety on Drug Safety Withdrawals, December 2002
  • Letter Urging FDA to Review Safety and Efficacy of All Pharmaceuticals Marketed Prior to 1938, May 29, 1996

You might be interested in

Press release on Unethical Use of Placebo in Study of HIV Prevention

February 18, 1998

Letter to the FDA Opposing Resumption of Clinical Trials Testing Anti-Nerve Growth Factor Drugs

April 16, 2012

Outrage of the Month: Company Tested Unapproved Implanted Drug on Louisiana Prisoner in Apparent Illegal Clinical Trial

December 1, 2019

Public Citizen poses serious concerns to the FDA about the testing of liraglutide in children

September 15, 2011

Stay Updated on Public Citizen

Follow Public Citizen

  • Facebook
  • Facebook
  • Facebook
  • Facebook
  • Facebook
  • Facebook

Support Our Work

Donate

Donate

  • Donate
  • Join/Renew
  • Giving Through Your Will
  • Gift of Stocks or Mutual Funds
  • Tax-Deductible Giving
  • Charitable Gift Annuities
  • Gifts From Your Retirement Account
  • Life Insurance Donations

Copyright © 2022 Public Citizen

  • Privacy Policy
  • Terms of Use
  • Careers
  • Contact

This website is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.